Navigation Links
Neurological Wellness Center Posts 700% Sales Increase in 2012; Enters Strategic Alliance with Enbrel Buyer's Club to Provide Low Cost Enbrel

Harmony, CA (PRWEB) January 09, 2013

Individuals purchasing a prescription drug for an off-label use are frequently denied insurance coverage. This is particularly true for expensive non-generic drugs like Enbrel. Neurological Wellness Center has provided instruction on the perispinal administration of Enbrel to thousands around the world. All too often the high price of Enbrel is the primary impediment stopping individuals from receiving this treatment that so dramatically improves people’s lives.

Membership in the newly-launched Enbrel Buyer’s Club is free. Members purchase Enbrel through Direct Prescription Service (DPS), a full-service on-line pharmacy service located in Winnipeg, Manitoba Canada. All Enbrel is the genuine product manufactured for Amgen/Pfizer by Immunex Corporation in California. DPS pharmacy provides consultation with licensed pharmacists. They offer convenient credit card payment and worldwide Express Mail® shipping at no charge. Expedient delivery with on-line tracking is guaranteed.

The price for one box containing four vials of 25 mg Enbrel powder is $795. If an Enbrel Buyer’s Club member purchases three or more boxes, the price drops to $765/box.

To buy Enbrel cheap visit: or contact DPS Prescription Service directly, toll free: 866-220-3551 or international 204-339-2197 or email: pharmacyorder(at)shaw(dot)ca. At $765 per box, this is approximately $200 cheaper than the lowest available on-line price.

If one’s insurance company reimbursement is applicable, DPS will provide order and delivery confirmation as requested by insurance companies to facilitate expedient reimbursement. A valid prescription is required to purchase Enbrel. Enbrel Buyer’s Club members may purchase other prescription drugs at mega discounts through DPS pharmacy. Enbrel Buyer’s Club is proud to recommend DPS pharmacy for all your prescription drug needs. To contact Enbrel Buyer’s Club email: mcdlov(at)gmail(dot)com.

The broad therapeutic role of Enbrel is based on the fact that TNF-alpha is the master regulator of the inflammatory response in many organ systems throughout the body. Enbrel is a large protein molecule that binds to TNF-alpha effectively neutralizing and down regulating the body’s inflammatory response.    The perispinal injection itself, as Neurological Wellness Center teaches it is extremely safe. The injection is a simple subcutaneous injection performed with a fine gauge half-inch needle. This injection is a unique form of subcutaneous injection. The precise location of the injection site and the proper positioning of the person receiving the injection are critical for successful administration. This procedure is illustrated in step-by-step fashion in the 24-minute video and 25-page e-book. This video and e-book is available via instant streaming access for $49, visit:

Safety issues pertaining to the drug Enbrel are covered on the website. Although Enbrel is a widely used drug with over 400,000 Americans self-injecting it weekly, it is not suitable for everyone. The Enbrel dosing schedule we counsel in our on-line course is generally quite low compared to the maximums recommended by Amgen/Pfizer for the treatment of rheumatoid plaque psoriasis.

Tumor necrosis factor-alpha (TNF-alpha) is a cytokine produced by monocyte and macrophage white blood cells, which acts as the master regulator of the human inflammatory response. Excess TNF-alpha in the brain can disrupt synaptic communication. Excess TNF-alpha triggers a cycle whereby toxic amyloid-beta is produced. This results in greater levels of pro-inflammatory TNF-alpha. Enbrel was developed to treat various inflammatory diseases by binding to TNF-alpha, effectively neutralizing its ability to act on cell membranes. Perispinal Enbrel treatment has a rapid effect reversing cognitive impairment and validating the role excess TNF-alpha plays in the disease processes of Alzheimer’s, stroke and traumatic brain injury. Enbrel’s long half-life (70 to 132 hours) enables a series of treatments to produce sequential progressive improvements in cognitive function that can be maintained long term.

The standard method for delivering CNS-active medication to the brain is via the blood. Enbrel, a large protein molecule, is unable to cross the blood-brain barrier. A subcutaneous perispinal injection to the fatty tissues at the back of the neck enables etanercept to enter the brain by lymph and venous drainage assisted by gravity.”

To learn more about perispinal Enbrel as a treatment for Alzheimer’s, stroke or traumatic brain injury and to purchase this $49 on-line course, please visit:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Ivy Neurological Sciences Internship program funded at TGen
2. Kids With Neurological Conditions at Higher Risk of Flu Death: CDC
3. New national clinical trials network for neurological disorders to foster cutting-edge treatments
4. The hidden disorder: Unique treatment proposed for childrens neurological disorder
5. Cedars-Sinai physician-scientist awarded $3M to study most common inherited neurological disorder
6. University Hospitals Neurological Institute to present 6th International 2013 Epilepsy Colloquium
7. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
8. Neurological Wellness Center Pays Tribute to Newly Released Study Announcing TBI Treatment Breakthrough
9. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
10. FirstVitals Health and Wellness, Inc. awarded $4 Million CMS Innovation Grant for Unique Telehealth Diabetes Progam Focused on Glycemic Control and Prevention of Diabetic Foot Complications
11. Fieldtex Products Launches a New Wellness Rewards Service for Companies
Post Your Comments:
(Date:11/25/2015)... ... , ... Finnleo, a leader in the traditional and far-infrared sauna industry, announced ... saunas. , For traditional saunas, Finnleo is offering 20% off all ... Finnleo uses only European Grade A Nordic White Spruce from sustainably grown trees. Because ...
(Date:11/25/2015)... ... 2015 , ... TyloHelo Inc , North America’s largest ... accessories help improve the bather experience in the sauna, and the accessories selected ... purist looking for simplicity in design to accessories that encourage a greater expression ...
(Date:11/25/2015)... ... November 26, 2015 , ... ... European Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, ... (UNON) for the opening of the 5th African Network for Drugs and Diagnostics ...
(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to MAP ... the two groups began in 2014 with Vitalalert pledging a portion of every purchase ... in 1954 and is an international Christian-based health organization whose mission is to “advance ...
(Date:11/25/2015)... FL (PRWEB) , ... November 25, 2015 , ... ... center, is encouraging people across the country to celebrate their sobriety and show ... people to post “before and after” photos this Thanksgiving with the hashtag #FacesOfGratitude ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... ser potential att använda SyMRI för att ... för patienter med multipel skleros (MS) eller ... SyntheticMR AB för att kunna använda SyMRI ... Med SyMRI kan man generera flera konstrastbilder ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... OAKS, Calif. , Nov. 25, 2015  Amgen ... a Biologics License Application (BLA) with the ... (FDA) for ABP 501, a biosimilar candidate to Humira ... first adalimumab biosimilar application submitted to the FDA and ... pathway. Sean E. Harper , M.D., executive ...
Breaking Medicine Technology: